Skip to content

20/20 Biolabs’ Multi-Cancer Early Detection Blood Test Selected by State of Vermont

20/20 Biolabs, an early market entrant in AI-powered laboratory blood tests, announces its OneTestâ„¢ multi-cancer early detection blood test has been selected for a firefighter cancer screening initiative in Vermont. The initiative aims to screen up to 4,500 firefighters and is expected to generate approximately $500,000 in testing revenues for the company. The program includes ultrasound services and aims to identify cancers earlier for improved treatment outcomes, responding to the elevated cancer risks firefighters face due to occupational exposures. The OneTestâ„¢ is designed to combine cancer-associated biomarkers with clinical factors and artificial intelligence to enhance cancer detection.

20/20 Biolabs’ Multi-Cancer Early Detection Blood Test Selected by State of Vermont to Screen up to 4,500 Firefighters